These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 22223611
21. Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H. Sánchez-Corral P, González-Rubio C, Rodríguez de Córdoba S, López-Trascasa M. Mol Immunol; 2004 May; 41(1):81-4. PubMed ID: 15140578 [Abstract] [Full Text] [Related]
23. IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome. Cugno M, Berra S, Depetri F, Tedeschi S, Griffini S, Grovetti E, Caccia S, Cresseri D, Messa P, Testa S, Giglio F, Peyvandi F, Ardissino G. J Am Soc Nephrol; 2021 May 03; 32(5):1227-1235. PubMed ID: 33712527 [Abstract] [Full Text] [Related]
24. Atypical hemolytic uremic syndrome: Korean pediatric series. Lee JM, Park YS, Lee JH, Park SJ, Shin JI, Park YH, Yoo KH, Cho MH, Kim SY, Kim SH, Namgoong MK, Lee SJ, Lee JH, Cho HY, Han KH, Kang HG, Ha IS, Bae JS, Kim NK, Park WY, Cheong HI. Pediatr Int; 2015 Jun 03; 57(3):431-8. PubMed ID: 25443527 [Abstract] [Full Text] [Related]
25. Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome. Abarrategui-Garrido C, Melgosa M, Peña-Carrión A, de Jorge EG, de Córdoba SR, López-Trascasa M, Sánchez-Corral P. Am J Kidney Dis; 2008 Jul 03; 52(1):171-80. PubMed ID: 18423815 [Abstract] [Full Text] [Related]
26. The role of defective complement control in hemolytic uremic syndrome. Zipfel PF, Misselwitz J, Licht C, Skerka C. Semin Thromb Hemost; 2006 Mar 03; 32(2):146-54. PubMed ID: 16575689 [Abstract] [Full Text] [Related]
28. Standardisation of the factor H autoantibody assay. Watson R, Lindner S, Bordereau P, Hunze EM, Tak F, Ngo S, Zipfel PF, Skerka C, Dragon-Durey MA, Marchbank KJ. Immunobiology; 2014 Jan 03; 219(1):9-16. PubMed ID: 23891327 [Abstract] [Full Text] [Related]
29. An ELISA assay with two monoclonal antibodies allows the estimation of free factor H and identifies patients with acquired deficiency of this complement regulator. Nozal P, Garrido S, Alba-Domínguez M, Espinosa L, Peña A, Córdoba SR, Sánchez-Corral P, López-Trascasa M. Mol Immunol; 2014 Apr 03; 58(2):194-200. PubMed ID: 24378252 [Abstract] [Full Text] [Related]
30. Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome. Feng S, Eyler SJ, Zhang Y, Maga T, Nester CM, Kroll MH, Smith RJ, Afshar-Kharghan V. Blood; 2013 Aug 22; 122(8):1487-93. PubMed ID: 23847193 [Abstract] [Full Text] [Related]
39. Anti-Factor H Antibody-Associated Atypical Hemolytic Uremic Syndrome: A Case Report. Abazi-Emini N, Sahpazova E, Putnik J, Tasic V. Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Oct 26; 42(2):109-115. PubMed ID: 34699711 [Abstract] [Full Text] [Related]